Detalhe da pesquisa
1.
Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health.
Curr Osteoporos Rep
; 21(4): 386-400, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37289382
2.
Abaloparatide Effects on Cortical Volumetric BMD and Estimated Strength Indices of Hip Subregions by 3D-DXA in Women With Postmenopausal Osteoporosis.
J Clin Densitom
; 25(3): 392-400, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35033435
3.
Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis.
J Clin Densitom
; 22(1): 1-19, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30366683
4.
Immobilization of Denosumab on Titanium Affects Osteoclastogenesis of Human Peripheral Blood Monocytes.
Int J Mol Sci
; 20(5)2019 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-30813507
5.
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice.
Calcif Tissue Int
; 99(1): 99-109, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26945756
6.
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine.
Eur Heart J
; 40(33): 2825-2830, 2019 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30169643
7.
Transient muscle paralysis degrades bone via rapid osteoclastogenesis.
FASEB J
; 26(3): 1110-8, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22125315
8.
Twelve Months of Denosumab and/or Alendronate Is Associated With Improved Bone Fatigue Life, Microarchitecture, and Density in Ovariectomized Cynomolgus Monkeys.
J Bone Miner Res
; 38(3): 403-413, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36533719
9.
Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman Primates.
J Bone Joint Surg Am
; 105(15): 1145-1155, 2023 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37159527
10.
Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide.
JCI Insight
; 8(20)2023 Oct 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37870958
11.
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.
Endocr Rev
; 29(2): 155-92, 2008 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18057140
12.
Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability.
Calcif Tissue Int
; 90(4): 330-42, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22382900
13.
Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA).
JBMR Plus
; 6(4): e10612, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35434451
14.
Denosumab treatment is associated with decreased cortical porosity and increased bone density and strength at the proximal humerus of ovariectomized cynomolgus monkeys.
Bone
; 164: 116517, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35961611
15.
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
J Biol Chem
; 285(36): 28164-73, 2010 Sep 03.
Artigo
Inglês
| MEDLINE | ID: mdl-20558734
16.
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice.
Am J Pathol
; 175(2): 473-8, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19590040
17.
Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.
Am J Pathol
; 174(6): 2160-71, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19389927
18.
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects.
Sci Rep
; 10(1): 16217, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33004873
19.
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.
Circulation
; 117(3): 411-20, 2008 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-18172035
20.
The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis.
J Clin Immunol
; 29(2): 158-74, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18726678